Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.

Beccari, Mario V; Seabury, Robert W; Mogle, Bryan T; Kufel, Wesley D; Miller, Christopher D; Steele, Jeffrey M

Beccari, Mario V; Seabury, Robert W; Mogle, Bryan T; Kufel, Wesley D; Miller, Christopher D; Steele, Jeffrey M.

J Am Pharm Assoc (2003) ; 60(5): 729-733, 2020.

Article in En | MEDLINE | ID: mdl-32224054

Subject(s)

Bacteremia; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Anti-Bacterial Agents/therapeutic use; Area Under Curve; Bacteremia/drug therapy; Bayes Theorem; Costs and Cost Analysis; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections/drug therapy; Vancomycin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Staphylococcal Infections / Bacteremia / Methicillin-Resistant Staphylococcus aureus Type of study: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limits: Humans Language: En Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google